PROBAN aims at reducing the pressure on patients and health systems with better informed decisions for the downstream healthcare choices and at decreasing the associated cost burden.
HOSPITAL / CLINIC / PHARMACY
INNOVATING DIAGNOSTICS FOR BETTER OUTCOMES
PROBAN is a non-invasive test that will benefit patients, medical doctors and health insurances / healthcare system.
PROBAN reduces burden on patients, improves accuracy and lowers costs.
Learn more about PROBAN and the transformative impact it has on patients, medical doctors, and the healthcare system.
PROBAN offers a reduced diagnostic burden on patients, by its non-invasive nature and simple application, and an improved quality of life, by reducing the number of individuals who need to perform unnecessary prostate biopsies and their related side-effects.
Urologists & family doctors
Medical doctors will be provided with an innovative and non-invasive diagnostic tool to select individuals at risk of harboring a prostate carcinoma and, most importantly, to not misdiagnose those men who would actually benefit from the prostate biopsy to detect the tumor at an early stage.
Health Insurances - Healthcare system
The implementation of a urine test with significant lower costs compared to a biopsy, and the substantial reduction in number of prostate biopsies, will result in an overall reduction of the healthcare costs related to the screening and diagnosis of prostate cancer.